Edith Cowan University (ECU) researchers have developed the world’s first blood test capable of detecting melanoma in its early stages, a breakthrough that will save thousands of lives, as well as millions of dollars for the health system.
In a trial involving 105 people with melanoma and 104 healthy controls, the blood test was able to detect early stage melanoma in 79 per cent of cases.
Australia has the second highest rate of melanoma in the world, with 14,000 new diagnoses and almost 2000 deaths each year.
Lead researcher PhD candidate Pauline Zaenker said identifying melanoma early was the best way to preventing these deaths.
“Patients who have their melanoma detected in its early stage have a five year survival rate between 90 and 99 per cent, whereas if it is not caught early and it spreads around the body, the five year survival rate drops to less than 50 per cent,” she said.
“This is what makes this blood test so exciting as a potential screening tool because it can pick up melanoma in its very early stages when it is still treatable.”
Currently the main way melanoma is detected is by a visual scan by a clinician with any areas of skin that are of concern excised and sent for a biopsy.
Ms Zaenker, from ECU’s Melanoma Research Group (MRG), said the new blood test could provide doctors with a powerful new tool to detect melanoma before it spreads throughout the body.
“While clinicians do a fantastic job with the tools available, relying on biopsies alone can be problematic. We know that three out of four biopsies come back negative for melanoma,” she said.
“The biopsies are quite invasive, with a minimum of 1cm by 1cm of skin excised from the patient.
“They are also costly, with previous research showing that the Australian health system spends $201 million on melanoma each year with an additional $73 million on negative biopsies.”
Antibodies provide early warning
The blood test works by detecting the autoantibodies the body produces in response to the melanoma.
“The body starts producing these antibodies as soon as melanoma first develops which is how we have been able to detect the cancer in its very early stages with this blood test. No other type of biomarker appears to be capable of detecting the cancer in blood at these early stages.” Ms Zaenker said.
“We examined a total of 1627 different types of antibodies to identify a combination of 10 antibodies that best indicated the presence of melanoma in confirmed patients relative to healthy volunteers.”
MelanomaWA Chief Executive Officer Clinton Heal knows first-hand the importance of developing new ways to detect skin cancer – he has had 34 secondary tumours removed since he was diagnosed with melanoma at the age of 22.
“At MelanomaWA we see first-hand the importance of early detection and how it’s critical to the long term survival of people diagnosed with melanoma,” he said.
“I am personally so excited to see this research transcending into clinical practice, having given of my own blood samples to the Melanoma Research Group following my diagnosis in 2005.
“My primary melanoma was not detected early, and I believe a simple blood test could have drastically improved my melanoma diagnosis and subsequent treatment since.”
MRG head Professor Mel Ziman said a follow up clinical trial to validate the findings was being organised.
“We envision this taking about three years. If this is successful we would hope to be able to have a test ready for use in pathology clinics shortly afterwards,” she said.
“The ultimate goal is for this blood test to be used to provide greater diagnostic certainty prior to biopsy and for routine screening of people who are at a higher risk of melanoma, such as those with a large number of moles or those with pale skin or a family history of the disease.”
The blood test (MelDx) has been submitted for an international patent.
Receive an email update when we add a new MELANOMA article.
The Latest on: Melanoma
via Google News
The Latest on: Melanoma
- Melanoma Research at University of Iowa on April 17, 2019 at 8:00 am
Melanoma is the deadliest form of skin cancer because it easily spreads to other vital organs and is hard to fight. Dr. Michael Henry from University of Iowa Hospitals explains the newest melanoma ... […]
- Melanoma Monday: The fight against skin cancer begins in your head – act now on April 17, 2019 at 4:41 am
A melanoma skin cancer campaign has been launched to raise awareness and promote the prevention, early detection and treatment of the commonest skin-related cause of death worldwide. Monday 6 May will ... […]
- It's Melanoma Awareness Month. Pledge to take better care of your skin. on April 16, 2019 at 2:37 pm
It's Melanoma Awareness Month. Pledge to take better care of your skin. The American Cancer Society says more than 96,000 new melanomas will be diagnosed in 2019, and 7,230 people will die from ... […]
- Acral Lentiginous Melanoma Market 2019 – 2025 Analysis Scrutinized in new research | Chiron Corporation, Prometheus Laboratories, on April 16, 2019 at 7:37 am
The report on the global Acral Lentiginous Melanoma market is comprehensively prepared with main focus on the competitive landscape, geographical growth, segmentation, and market dynamics, including ... […]
- New treatment available for non-melanoma skin cancer on April 16, 2019 at 5:22 am
PHOENIX (3TV/CBS 5) --More people have skin cancer than any other cancer and the numbers just keep rising. In fact, more than 3.5 million cases are diagnosed in the U.S. each year and experts say the ... […]
- Mechanism of resistance to BRAF inhibitors in melanoma identified on April 15, 2019 at 1:41 pm
Melanoma is one of the most aggressive types of skin cancer, but recent advances in targeted therapies have improved the prognosis for many patients. Unfortunately, for some patients these positive ... […]
- Researchers identify mechanism of resistance to BRAF inhibitors in melanoma on April 15, 2019 at 9:14 am
Melanoma is one of the most aggressive types of skin cancer, but recent advances in targeted therapies have improved the prognosis for many patients. Unfortunately, for some patients these ... […]
- ONS Chapter Addresses Prevention, Early Detection of Melanoma Through “Hairstylist Melanoma Challenge” on April 13, 2019 at 5:45 pm
The following article features coverage from the Oncology Nursing Society (ONS) 2019 Annual Congress. Click here to read more of Oncology Nurse Advisor‘s conference coverage. ANAHEIM, CA — Learning of ... […]
- Skin cancer cases on the rise and it's not just melanoma you need to keep an eye on on April 12, 2019 at 10:38 pm
SAN FRANCISCO (KGO) -- Skin cancer is the most common cancer on earth, and according to new research, it's not going anywhere any time soon. According to the American Cancer Society melanoma, one ... […]
via Bing News